End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,410 KRW | +2.40% | -0.62% | -28.54% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
Sales 2022 | 1,034B 752M 1.03B | Sales 2023 | 349B 253M 346M | Capitalization | 303B 220M 301M |
---|---|---|---|---|---|
Net income 2022 | 347B 252M 344M | Net income 2023 | -3.17B -2.31M -3.15M | EV / Sales 2022 | -0.01 x |
Net cash position 2022 | 423B 308M 420M | Net cash position 2023 | 274B 199M 272M | EV / Sales 2023 | 0.08 x |
P/E ratio 2022 |
1.32
x | P/E ratio 2023 |
-95.5
x | Employees | 101 |
Yield 2022 |
6.75% | Yield 2023 |
-
| Free-Float | 0% |
1 day | +2.40% | ||
1 week | -0.62% | ||
Current month | -14.08% | ||
1 month | -14.08% | ||
3 months | -23.51% | ||
6 months | -23.69% | ||
Current year | -28.54% |
Managers | Title | Age | Since |
---|---|---|---|
Young-Ho Choi
CEO | Chief Executive Officer | 60 | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Ho Choi
CEO | Chief Executive Officer | 60 | 01-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 6,410 | +2.40% | 52,589 |
24-04-26 | 6,260 | -1.88% | 70,369 |
24-04-25 | 6,380 | -0.78% | 43,467 |
24-04-24 | 6,430 | 0.00% | 44,474 |
24-04-23 | 6,430 | -0.31% | 52,191 |
End-of-day quote Korea S.E., April 28, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-28.54% | 154M | |
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.48% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+3.45% | 1.64B |
- Stock Market
- Equities
- A950130 Stock